When a patient is first diagnosed with a breast tumor, the initial needle biopsy is usually the roadmap for treatment. However, a rare type of cancer called malignant breast adenomyoepithelioma (MAME) can be tricky. In one case involving an 84-year-old woman, the initial biopsy suggested a common form of cancer, but the final surgical tests revealed it was actually MAME.
A review of other cases shows this mix-up happens often. While these tumors are rare and don't frequently spread to lymph nodes, they can look very similar to more common cancers on early tests. This makes it important for doctors to use detailed chemical testing (immunohistochemistry) during the first biopsy to get the right diagnosis.
The patient in this report underwent surgery and chemotherapy. While she experienced a mild side effect called hand-foot syndrome, her surgical margins were clear. Because MAME is so rare and these cases are few, we still have limited data on long-term outcomes, but the findings highlight why detailed testing matters from the very start.
